迈克生物
(300463)
| 流通市值：62.91亿 | | | 总市值：77.78亿 |
| 流通股本：4.95亿 | | | 总股本：6.12亿 |
| 报告期 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 819,182,542.14 | 835,957,326.8 | 769,659,867.28 | 854,670,123.43 |
| 应收票据及应收账款 | 1,738,359,591.84 | 1,793,562,431.7 | 1,794,078,380.35 | 1,872,713,774.87 |
| 其中：应收票据 | 30,839,801.25 | 20,258,570.53 | 62,498,036.68 | 64,789,730.72 |
| 应收账款 | 1,707,519,790.59 | 1,773,303,861.17 | 1,731,580,343.67 | 1,807,924,044.15 |
| 应收款项融资 | 33,969,572.52 | 40,087,754.03 | 41,790,205.21 | 38,004,909.42 |
| 预付款项 | 236,400,953.65 | 193,690,189.35 | 233,232,621.45 | 155,600,812.19 |
| 其他应收款合计 | 28,984,654.5 | 27,651,809.87 | 24,859,165.76 | 23,757,434.24 |
| 存货 | 1,009,803,399.09 | 907,488,528.28 | 1,092,427,033.96 | 1,081,831,910.01 |
| 其他流动资产 | 114,066,380.79 | 112,635,352.15 | 106,811,882.96 | 98,206,207.62 |
| 流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 流动资产合计 | 4,121,289,063.21 | 4,222,217,919.77 | 4,474,641,293.96 | 4,597,117,752.6 |
| 非流动资产: | | | | |
| 长期股权投资 | - | - | 0 | - |
| 其他权益工具投资 | 139,340,058.54 | 139,767,887.32 | 131,139,709.39 | 140,298,933.34 |
| 其他非流动金融资产 | 31,996,437.55 | 32,957,264.85 | 27,471,958.19 | 33,610,248.58 |
| 投资性房地产 | 66,055,457.83 | 66,519,747.01 | 66,984,036.19 | 67,448,325.37 |
| 固定资产 | 2,194,615,191.38 | 2,186,644,511.57 | 2,069,996,793.98 | 1,992,882,520.59 |
| 在建工程 | 811,872,935.65 | 714,480,697.52 | 681,061,058.2 | 642,334,530.48 |
| 使用权资产 | 24,796,080.81 | 28,328,456.06 | 25,458,870.93 | 27,122,765.63 |
| 无形资产 | 305,413,446.66 | 283,250,717.77 | 306,392,862.35 | 261,002,015.95 |
| 开发支出 | 125,343,217.81 | 137,544,414.42 | 110,248,902.76 | 137,648,034.02 |
| 商誉 | 145,145,637.79 | 145,145,637.79 | 145,145,637.79 | 145,145,637.79 |
| 长期待摊费用 | 4,661,374.4 | 4,860,298.96 | 5,772,016.61 | 6,700,376.15 |
| 递延所得税资产 | 150,301,980.38 | 153,863,904.46 | 173,271,980.15 | 178,135,243.5 |
| 其他非流动资产 | 3,667,850.43 | 3,667,850.43 | 15,113,607.43 | 5,748,407.43 |
| 非流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 非流动资产合计 | 4,003,209,669.23 | 3,897,031,388.16 | 3,758,057,433.97 | 3,638,077,038.83 |
| 资产平衡项目 | 0 | 0 | 0 | 0 |
| 资产总计 | 8,124,498,732.44 | 8,119,249,307.93 | 8,232,698,727.93 | 8,235,194,791.43 |
| 流动负债: | | | | |
| 短期借款 | 198,264,245.11 | 144,647,498.1 | 292,292,986.73 | 300,020,823.94 |
| 应付票据及应付账款 | 289,346,806.8 | 365,846,161.95 | 418,116,810.99 | 368,070,998.27 |
| 其中：应付票据 | 22,444,386.4 | 80,472,270 | 76,495,680 | 5,800,000 |
| 应付账款 | 266,902,420.4 | 285,373,891.95 | 341,621,130.99 | 362,270,998.27 |
| 合同负债 | 84,087,896.15 | 72,358,985.11 | 65,666,050.23 | 83,659,842.49 |
| 应付职工薪酬 | 49,108,655.23 | 116,724,296.57 | 43,715,062.35 | 41,835,297.32 |
| 应交税费 | 36,767,207.91 | 41,002,035.55 | 56,230,563.38 | 42,569,186.03 |
| 其他应付款合计 | 22,889,667.94 | 24,995,300.22 | 21,150,975.09 | 18,893,124.43 |
| 一年内到期的非流动负债 | 391,919,677.7 | 345,039,677.7 | 300,653,273.13 | 199,995,009.17 |
| 其他流动负债 | 10,087,651.02 | 9,991,155.32 | 8,639,110.44 | 10,808,494.11 |
| 流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 流动负债合计 | 1,082,471,807.86 | 1,120,605,110.52 | 1,206,464,832.34 | 1,065,852,775.76 |
| 非流动负债: | | | | |
| 长期借款 | 112,000,000 | 162,500,000 | 202,500,000 | 423,500,000 |
| 租赁负债 | 9,428,919.74 | 12,977,946.3 | 14,637,754.3 | 15,538,446.59 |
| 预计负债 | 3,828,800 | 3,828,800 | - | - |
| 递延收益 | 28,801,835.88 | 28,801,835.88 | 31,333,864.42 | 31,283,864.42 |
| 递延所得税负债 | 175,484,420.49 | 179,073,594.69 | 210,184,903.58 | 219,516,779.17 |
| 非流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 非流动负债合计 | 329,543,976.11 | 387,182,176.87 | 458,656,522.3 | 689,839,090.18 |
| 负债平衡项目 | 0 | 0 | 0 | 0 |
| 负债合计 | 1,412,015,783.97 | 1,507,787,287.39 | 1,665,121,354.64 | 1,755,691,865.94 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 612,469,590 | 612,469,590 | 612,469,590 | 612,469,590 |
| 资本公积 | 1,780,989,744.69 | 1,780,989,744.69 | 1,782,448,204.93 | 1,782,448,204.93 |
| 减:库存股 | 193,040,926.79 | 170,181,677.97 | 170,181,677.97 | 170,181,677.97 |
| 其他综合收益 | 14,529,615.09 | 14,893,264.45 | 6,385,150.4 | 14,170,490.76 |
| 盈余公积 | 306,234,795 | 306,234,795 | 306,234,795 | 306,234,795 |
| 未分配利润 | 3,960,861,803.07 | 3,840,419,554.17 | 3,796,395,136.58 | 3,702,554,409.58 |
| 归属于母公司股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 归属于母公司股东权益合计 | 6,482,044,621.06 | 6,384,825,270.34 | 6,333,751,198.94 | 6,247,695,812.3 |
| 少数股东权益 | 230,438,327.41 | 226,636,750.2 | 233,826,174.35 | 231,807,113.19 |
| 股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 股东权益合计 | 6,712,482,948.47 | 6,611,462,020.54 | 6,567,577,373.29 | 6,479,502,925.49 |
| 负债和股东权益合计 | 8,124,498,732.44 | 8,119,249,307.93 | 8,232,698,727.93 | 8,235,194,791.43 |
| 公告日期 | 2024-04-25 | 2024-04-25 | 2023-10-26 | 2023-07-29 |
| 审计意见(境内) | | 标准无保留意见 | | |